Genomic Solutions Q3 Revenue Slips 28 Percent, Losses Widen | GenomeWeb

NEW YORK, Nov. 1 – Struggling microarray and proteomics company Genomic Solutions said Thursday its third-quarter revenues slipped 28 percent to $3.6 million, compared with $5 million in the year ago period, as its net losses widened.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."